Announced Fri, 26 Jun · 09:53 IST
Trading Window closed from July 1 till Q1 FY27 results
Compliance View source PDF
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+7.3%1-day move
₹3191.00
prior close
₹3180.40
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.5+1.4+1.7+2.4+7.3+4.8+4.7+4.6+5.8+2.9+8.6———
Up moveDown movePending
AI summary
Ajanta Pharma has closed its trading window from Wednesday, July 1, 2026 until 48 hours after the company declares its financial results for the quarter ended June 30, 2026. This is a routine compliance measure under SEBI insider trading regulations, restricting directors, employees and other insiders from trading in the company shares during this period. The closure signals that the Q1 FY27 earnings announcement is approaching.
Likely market impact
Routine compliance filing, no direct price impact. Indicates Q1 FY27 results are due soon, which may move the stock.